3 takeover targets in immunology

3 takeover targets in immunology is a pharma and life sciences industry update from PharmaVoice. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.

Kelly Bilodeau · 2026-08-26

Dealmaking in the autoimmune space is thriving as biotechs chase new targets with the potential to treat more conditions.

Source: PharmaVoice